D
Cardiff Oncology, Inc. CRDF
$4.00 $0.051.27%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -11.79M -11.86M -11.78M -10.01M -9.34M
Total Depreciation and Amortization 96.00K 101.00K 105.00K 102.00K 103.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.05M 1.10M 1.05M 968.00K 704.00K
Change in Net Operating Assets 378.00K 202.00K 1.39M 1.20M 1.39M
Cash from Operations -10.27M -10.46M -9.23M -7.74M -7.14M
Capital Expenditure 0.00 0.00 0.00 -80.00K -8.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 4.51M -9.43M 14.02M 4.72M 13.57M
Cash from Investing 4.51M -9.43M 14.02M 4.64M 13.56M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 44.19M 7.43M 2.06M 107.00K --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 44.19M 7.43M 2.06M 107.00K --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 38.43M -12.46M 6.84M -3.00M 6.42M
Weiss Ratings